Moon, J.-J.; Choi, Y.; Kim, K.-H.; Seo, A.; Kwon, S.; Kim, Y.-C.; Kim, D.-K.; Kim, Y.-S.; Yang, S.-H.
Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis. Biomedicines 2022, 10, 1345.
https://doi.org/10.3390/biomedicines10061345
AMA Style
Moon J-J, Choi Y, Kim K-H, Seo A, Kwon S, Kim Y-C, Kim D-K, Kim Y-S, Yang S-H.
Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis. Biomedicines. 2022; 10(6):1345.
https://doi.org/10.3390/biomedicines10061345
Chicago/Turabian Style
Moon, Jong-Joo, Yejin Choi, Kyu-Hyeon Kim, Areum Seo, Soie Kwon, Yong-Chul Kim, Dong-Ki Kim, Yon-Su Kim, and Seung-Hee Yang.
2022. "Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis" Biomedicines 10, no. 6: 1345.
https://doi.org/10.3390/biomedicines10061345
APA Style
Moon, J. -J., Choi, Y., Kim, K. -H., Seo, A., Kwon, S., Kim, Y. -C., Kim, D. -K., Kim, Y. -S., & Yang, S. -H.
(2022). Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis. Biomedicines, 10(6), 1345.
https://doi.org/10.3390/biomedicines10061345